Can leronlimab serve as the standard of care for "
Post# of 148639
(Total Views: 424)
Posted On: 09/25/2024 9:28:24 AM
Can leronlimab serve as the standard of care for "inflammation"?
Inflammation is inherent in disease processes, infection, trauma, and environmental factors (chemical, pesticides, etc). Feel free to add to the list. Can leronlimab actually address inflammation at its core?
For the layperson, unfamiliar with leronlimab, it is difficult to wrap our minds around the dozens of indications that may be addressed. However, can leronlimab serve to mitigate generalized inflammation, not matter its cause? Is this now, or can it eventually be, a legitimate claim?
My questios were triggered by a speech given by Dr. Marty Makary, Johns Hopkins University, regarding his work with pancreatic cancer. I read it on "X", but couldn't copy and paste. I couldn't find it elsewhere. Is this discussion worth having?
Inflammation is inherent in disease processes, infection, trauma, and environmental factors (chemical, pesticides, etc). Feel free to add to the list. Can leronlimab actually address inflammation at its core?
For the layperson, unfamiliar with leronlimab, it is difficult to wrap our minds around the dozens of indications that may be addressed. However, can leronlimab serve to mitigate generalized inflammation, not matter its cause? Is this now, or can it eventually be, a legitimate claim?
My questios were triggered by a speech given by Dr. Marty Makary, Johns Hopkins University, regarding his work with pancreatic cancer. I read it on "X", but couldn't copy and paste. I couldn't find it elsewhere. Is this discussion worth having?
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼